1-7 of 7
Karen Sands
Close
Sort by
Journal Articles

Are Back-Up Bone Marrow Harvests of Value in Unrelated Donor Allogeneic Transplants?.

Christy Stotler, Edward Copelan, Ronald Sobecks, Lisa Rybicki, Robert Dean, Steven Andresen, Brad Pohlman, John William Sweetenham, Stacey Brown, Matt Kalaycio, Julie Curtis, Karen Sands, Mary Serafin, Jennifer Kosar, Brian Bolwell
Journal: Blood
Blood (2007) 110 (11): 5023.
https://doi.org/10.1182/blood.V110.11.5023.5023
Published: 2007
Journal Articles

Pre-Transplant Hypogammaglobulinemia Influences Survival after Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, Matt Kalaycio, Lisa Rybicki, Josephine Chan, Robert Dean, Karen Sands, Mary Serafin, Jennifer Kosar, Steve Andresen, Brad Pohlman, Edward Copelan, Brian Bolwell
Journal: Blood
Blood (2007) 110 (11): 1979.
https://doi.org/10.1182/blood.V110.11.1979.1979
Published: 2007
Journal Articles

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, MD, Karl Theil, MD, Lisa Rybicki, MS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Mary Serafin, RN, Karen Sands, RN, Jennifer Kosar, RN, Brian J. Bolwell, MD
Journal: Blood
Blood (2006) 108 (11): 2960.
https://doi.org/10.1182/blood.V108.11.2960.2960
Published: 2006
Journal Articles

Comparing Psychosocial Profiles and Outcomes between Patients Undergoing Myeloablative and Non-Myeloablative Allogeneic Transplants.

Linda McLellan, Larry W. Foster, Lisa Rybicki, Jane Dabney, Michele Visnosky, Sungren Sungren, Alison Vellani, Nicole Berry, Kelly Cherni, Laura Bernhard, Jennifer Kosar, Mary Serafin, Karen Sands, Christina Ferraro, Brian J. Bolwell
Journal: Blood
Blood (2006) 108 (11): 77.
https://doi.org/10.1182/blood.V108.11.77.77
Published: 2006
Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD
Journal: Blood
Blood (2005) 106 (11): 1322.
https://doi.org/10.1182/blood.V106.11.1322.1322
Published: 2005
Journal Articles

Improved Outcomes with Class I and II DNA-Based HLA Typing for Matched Unrelated Donor (MUD) Allogeneic Bone Marrow Transplant (ABMT) in Hematologic Diseases.

Ronald Sobecks, M.D., Edward J. Ball, PhD, Lisa Rybicki, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Karen Sands, R.N., Jennifer Kosar, R.N., Mary Serafin, R.N., Jennifer Bates, Christy Lalli, Brian Bolwell, M.D.
Journal: Blood
Blood (2004) 104 (11): 5181.
https://doi.org/10.1182/blood.V104.11.5181.5181
Published: 2004
Journal Articles

Outcomes Analysis of Patients Surviving ≥2 Years after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, M.D., Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Lisa Rybicki, Jennifer Kosar, R.N., Mary Serafin, R.N., Karen Sands, R.N., Christy Lalli, Stacey Brown, Elizabeth Kuczkowski, Brian Bolwell, M.D.
Journal: Blood
Blood (2004) 104 (11): 2762.
https://doi.org/10.1182/blood.V104.11.2762.2762
Published: 2004